Back to Search Start Over

Sun exposure influences the prognostic power of components of mineral metabolism in patients with coronary artery disease.

Authors :
Aceña A
Franco-Peláez JA
Gutierrez-Landaluce C
Pello AM
Cristóbal C
Tarín N
Huelmos A
Carda R
Martín-Mariscal ML
Alonso J
González-Parra E
González-Casaus ML
Lorenzo Ó
López Bescos L
Egido J
Tuñón J
Source :
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2017 Sep; Vol. 27 (9), pp. 762-767. Date of Electronic Publication: 2017 Jun 15.
Publication Year :
2017

Abstract

Background and Aim: Calcidiol (vitamin D metabolite) plasma levels vary with sun exposure (SE). However, it is not known if SE influences its prognostic ability. We have studied the effect of SE on plasma levels of the components of mineral metabolism (calcidiol, fibroblast growth factor-23 [FGF-23], parathormone [PTH], and phosphate [P]) and on their prognostic value in patients with coronary artery disease (CAD).<br />Methods and Results: We studied prospectively 704 patients with stable CAD. Clinical variables and baseline calcidiol, FGF-23, PTH, and P plasma levels were assessed. We divided the population in two subgroups, according to the period of plasma extraction: High SE (HSE) (April-September) and low SE (LSE) (October-March). The outcome was the development of acute ischemic events (acute coronary syndrome, stroke, or transient ischemic attack), heart failure, or death. Mean follow-up was 2.15 ± 0.99 years. Calcidiol and P levels were higher in HSE group. In the whole population, calcidiol (HR = 0.84 for each 5 ng/ml increase, 95% CI = 0.71-0.99; p = 0.038) and FGF-23 (HR = 1.14 for each 100 RU/ml increase, 95% CI = 1.05-1.23; p = 0.009) were predictors of the outcome, along with age, hypertension, body-mass index, peripheral artery disease, and P levels. In the LSE subgroup, calcidiol (HR = 0.75; 95% CI = 0.57-0.99; p = 0.034) and FGF-23 (HR = 1.34; 95% CI = 1.13-1.58; p = 0.003) remained as predictors of the outcome. In the HSE group calcidiol and FGF-23 had not independent prognostic value.<br />Conclusions: In patients with stable CAD, low calcidiol and high FGF-23 plasma levels predict an adverse prognosis only when the sample is obtained during the months with LSE. SE should be taken into account in the clinical practice.<br /> (Copyright © 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1590-3729
Volume :
27
Issue :
9
Database :
MEDLINE
Journal :
Nutrition, metabolism, and cardiovascular diseases : NMCD
Publication Type :
Academic Journal
Accession number :
28803689
Full Text :
https://doi.org/10.1016/j.numecd.2017.06.006